Published in Clin J Am Soc Nephrol on December 22, 2005
The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99
Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol (2010) 1.45
Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis (2010) 1.16
Cardio-renal syndromes: a systematic approach for consensus definition and classification. Heart Fail Rev (2012) 0.99
Uremic Toxicity of Advanced Glycation End Products in CKD. J Am Soc Nephrol (2015) 0.94
Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol (2009) 0.91
Endothelial factors and diabetic nephropathy. Diabetes Care (2011) 0.91
Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially. Heart Fail Rev (2011) 0.88
Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev (2012) 0.88
Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases. EPMA J (2011) 0.87
Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. Kidney Int (2012) 0.86
Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. Clin J Am Soc Nephrol (2013) 0.86
Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study. Cardiovasc J Afr (2012) 0.85
Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease. J Mol Cell Cardiol (2009) 0.84
The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin. Curr Cardiol Rev (2008) 0.83
Prophylactic Add-on Antiplatelet Therapy in Chronic Kidney Disease With Type 2 Diabetes Mellitus: Comparison Between Clopidogrel and Low-dose Aspirin. Int J Prev Med (2013) 0.81
Association of glomerular filtration rate with high-sensitivity cardiac troponin T in a community-based population study in Beijing. PLoS One (2012) 0.81
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. J Cachexia Sarcopenia Muscle (2011) 0.80
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia. Int J Mol Sci (2015) 0.79
Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Pediatr Nephrol (2015) 0.78
Preclinical cardiorenal interrelationships in essential hypertension. Cardiorenal Med (2013) 0.78
Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease. Pediatr Nephrol (2011) 0.77
Novel urinary tubular injury markers reveal an evidence of underlying kidney injury in children with reduced left ventricular systolic function: a pilot study. Pediatr Nephrol (2016) 0.77
Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol (2016) 0.77
Cardio-renal syndromes: from foggy bottoms to sunny hills. Heart Fail Rev (2011) 0.77
Emerging drug combinations to optimize renovascular protection and blood pressure goals. Int J Nephrol Renovasc Dis (2012) 0.76
Prevention and Treatment of CKD-MBD. Nephrourol Mon (2013) 0.76
A Case for Early Screening for Diabetic Kidney Disease. Cardiorenal Med (2011) 0.76
Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease. J Am Heart Assoc (2015) 0.75
Cardiovascular Collapse Associated With Irreversible Cardiomyopathy, Chronic Renal Failure, and Hypertension During Routine Dental Care. Anesth Prog (2016) 0.75
Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis (2014) 0.75
The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents. PLoS One (2014) 0.75
Functional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells. Am J Physiol Renal Physiol (2012) 0.75
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J (2006) 1.98
Anemia of kidney disease and clinical practice guidelines: quo vadis? Clin J Am Soc Nephrol (2007) 0.75